Sg Americas Securities, LLC Clearside Biomedical, Inc. Transaction History

Sg Americas Securities, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 06, 2024	BUY	$1.2 - $2.02 $38,724 - $65,185	32,270 New	32,270 $49,000
Q3 2019 Nov 04, 2019	SELL	$0.59 - $1.32 $9,759 - $21,834	-16,541 Closed	0 $0
Q2 2019 Jul 29, 2019	SELL	$0.97 - $1.42 $39,472 - $57,784	-40,693 Reduced 71.1%	16,541 $16,000
Q1 2019 Apr 29, 2019	BUY	$1.1 - $1.74 $24,434 - $38,650	22,213 Added 63.43%	57,234 $79,000
Q4 2018 Feb 01, 2019	BUY	$1.0 - $6.12 $35,021 - $214,328	35,021 New	35,021 $37,000

13.4M

17.6K

100

Ticker CLSD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 60,190,700
Market Cap $61.4M
Description
Clearside Biomedical, Inc., a biopharmaceutical company, focuses on the revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space. The company offers XIPERE, a triamcinolone acetonide suprachoroidal injectable suspension for the treatment of uveitis macular edema. It also develops CLS-AX, an axitinib injec...

Get notified when there are updates to the investment portfolio of Sg Americas Securities, LLC, based on Form 13F filings with the SEC.

Stay updated on Sg Americas Securities, LLC with notifications on news.